LITTLE FALLS, N.J.,
Feb. 16, 2017 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE:CMD), a leading global
company dedicated to delivering innovative infection prevention
products, services and solutions, announced today that it entered
into a definitive agreement to purchase its endoscopy business
assets from Australian distributor, CR Kennedy & Company Pty
Ltd. The endoscopy business assets consist of Cantel's
Medivators®-branded automated endoscope reprocessors,
chemistries, procedure room products and other consumables as well
as a full sales and service organization.
Jorgen B. Hansen, President and
CEO of Cantel Medical said, "This acquisition is in line with
Cantel's strategy to expand its products and services into key
markets to provide global solutions that meet local needs. It also
accelerates our ability to offer customers in Australia an expanded
Medivators®-branded product portfolio while maintaining
the high-quality service and support that our customers
expect."
"The expansion of our commercial platform and the addition of a
direct sales and service organization for our Endoscopy business
provides Cantel with near- and long-term growth opportunities. It
also broadens our leadership and strengthens our share in the
infection prevention market in Australia," stated David Rosen, President, Continental Europe,
Middle East and Asia-Pacific. "We would like to thank CR
Kennedy for the many years of outstanding support of the
Medivators® business in Australia and for their partnership and role
in helping us achieve this milestone."
Subject to customary closing conditions, Cantel expects the
transaction to close on or around April 1,
2017.
About Cantel Medical
Cantel Medical is a leading global company dedicated to delivering
innovative infection prevention products and services for patients,
caregivers, and other healthcare providers which improve outcomes,
enhance safety and help save lives. Our products include
specialized medical device reprocessing systems for endoscopy and
renal dialysis, advanced water purification equipment, sterilants,
disinfectants and cleaners, sterility assurance monitoring products
for hospitals and dental clinics, disposable infection control
products primarily for dental and GI endoscopy markets, dialysate
concentrates, hollow fiber membrane filtration and separation
products. Additionally, we provide technical service for our
products. For further information, visit the Cantel website
at www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cantel-medical-to-expand-direct-sales-operations-in-australia-300408905.html
SOURCE Cantel Medical Corp.